Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$254,563,898
+$14,488,269 QoQ
Shares Held
1,359,269
-44.9% QoQ
Ownership
0.634%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#32
of 687 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Dec 31, 2024CallValue
$13,848,084
CallShares
316,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $1,266,200,483 across 29 Biotechnology names. RVMD ranks #1 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
This page
|
1,359,269 | $254,563,898 | |
| 2 | DNLI |
Denali Therapeutics Inc.
|
3,905,225 | $100,442,387 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,144,579 | $97,506,685 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
1,755,978 | $96,578,790 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,106,177 | $90,164,487 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,015,170 | $90,126,792 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
152,924 | $82,112,541 | |
| 8 | TNGX |
Tango Therapeutics, Inc.
|
2,410,939 | $75,365,953 |
All Filings in RVMD
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,563,898 | 1,359,269 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $240,075,629 | 2,468,644 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $151,968,058 | 1,907,948 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $160,521,116 | 3,437,283 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $133,656,304 | 3,632,952 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $130,540,067 | 3,691,744 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,848,084 | 316,600 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $131,076,095 | 2,996,710 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $97,482,591 | 2,149,561 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $85,516,825 | 2,203,474 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $78,074,306 | 2,422,411 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $82,660,205 | 2,882,155 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $60,639,184 | 2,190,722 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $58,263,105 | 2,178,060 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $45,590,357 | 2,104,818 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||